SciSparc Ltd. (SPRC)

Nasdaq: SPRC · Pharmaceutical Preparations · Tel Aviv, IL · filing with the SEC since 2014

Full chart Alerts Compare

Grade3.9

◀ Past 3.3● Present 4.0▶ Future 4.2

3 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

The companyfiscal 2024, as filed

Revenue$1.3M-54.6%

Net income-$7.5M-27.0%

Earnings per share$1.28-91.1%

Operating cash flow-$5.1M+13.3%

Cash$1.5M-25.8%

Debtn/a

Shareholders’ equity$8.9M-6.8%

Shares, diluted5,824,972+1328.8%

Return on equity-83.6%

The recordfrom its filings

Filings in 202670

Newest filingNov 9 · F-3

Annual reportApr 29, 2026

Quarterly reportn/a

Next report due20-F by Apr 30

Insider sales, 12 months$0.00

Insider buys, 12 months$0.00

Patents granted5

Filer categoryNon-accelerated filer

Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.

Revenue and net income by fiscal yearRevenueNet income

15161718192021222324

As filed, in USD. Nothing here is a forecast.

News

Nov 9, 2026 · SEC EDGAR · Form F-3

Shelf registration, foreign filer

Open the filing on sec.gov

Nov 9, 2026 · SEC EDGAR · Form 6-K/A

Interim report, foreign filer, amended

Open the filing on sec.gov

Nov 3, 2026 · SEC EDGAR · Form 6-K

Interim report, foreign filer

Open the filing on sec.gov

Oct 26, 2026 · SEC EDGAR · Form 6-K

Interim report, foreign filer

Open the filing on sec.gov

Oct 23, 2026 · SEC EDGAR · Form 6-K

Interim report, foreign filer

Open the filing on sec.gov

Oct 15, 2026 · SEC EDGAR · Form 6-K

Interim report, foreign filer

Open the filing on sec.gov

Oct 15, 2026 · SEC EDGAR · Form 6-K

Interim report, foreign filer

Open the filing on sec.gov

Oct 7, 2026 · SEC EDGAR · Form 6-K

Interim report, foreign filer

Open the filing on sec.gov

Sep 30, 2026 · SEC EDGAR · Form 6-K

Interim report, foreign filer

Open the filing on sec.gov

Sep 24, 2026 · SEC EDGAR · Form 6-K

Interim report, foreign filer

Open the filing on sec.gov

An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.

SI brieffrom the record

Core business

SciSparc Ltd. is classed by the SEC under Pharmaceutical Preparations (industry code 2834), based in Tel Aviv, IL.

Newest on the record

Shelf registration, foreign filer on Nov 9. Before it, interim report, foreign filer, amended on Nov 9.

What is due next

The 20-F for the period to Dec 31, 2026, due by Apr 30, 2027.

About SPRC

SciSparc Ltd. is classed by the SEC under Pharmaceutical Preparations (industry code 2834), based in Tel Aviv, IL. In its latest annual figures on file, for the fiscal year ended 2024-12-31, it reported revenue of $1.3 million and a loss of $7.5 million (its filed statements).

IndustryPharmaceutical Preparations

HeadquartersTel Aviv, IL

Business modelPre-revenue company

ExchangeNasdaq

Filing since2014

Fiscal year endsDec 31

SEC number (CIK)1611746

Peers on fileLGVN, SHPH, GNPX, TRAW

Who runs it

Financial performance

In fiscal 2024 SciSparc’s revenue was $1.31 million, down 54.6% from $2.88 million the year before. It made a net loss of $7.47 million.

Annual report, filed Apr 29, 2026.

Financial statements

The grade

SciSparc grades 3.9 of 10 against its own industry, the 497 companies in Pharmaceutical Preparations. Six of the nine metrics are read as filed and three are SI estimates, each with its reasoning.

◀ Past3.3

● Present4.0

▶ Future4.2

How the grade is made

Forecast

Every forecast is registered before the outcome, with the rule that settles it. A miss stays on the page.

Company forecasts

SI Assistanton SPRC · research, not advice